S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Funds/RA Capital Management/Q2 2022

RA Capital Management

Period: Q2 2022 Β· Filed: 2022-08-15
View on SEC EDGAR β†—
AUM
$3.75B
Total portfolio value
Positions
88
Reported securities
Top Holding
ASND
18.8% $703.5M
QoQ Changes
+8 / -8
new Β· exited
⚠️13F Filing Disclosure

AUM figures shown are calculated by summing the reported market value of all positions in SEC 13F-HR filings β€” not the fund's actual assets under management.

  • Excludes cash, bonds, private equity, short positions, and foreign-listed stocks not required to be reported.
  • For PUT and CALL options, the reported Value is the notional value of the underlying shares β€” not the option premium paid. This significantly overstates the actual capital at risk.
  • Actual fund AUM is typically higher and includes strategies, instruments, and positions that never appear in a 13F.
  • 13F filings cover institutional managers with β‰₯$100M in 13F securities. Positions reflect end-of-quarter holdings, disclosed up to 45 days after the period ends.

Data sourced from SEC EDGAR. This tracker is for informational purposes only and does not constitute investment advice.

Portfolio Holdings

Top 30 positions

⚠️ Performance % calculated from filing date ( 2022-08-15) shown is the underlying stock price movement β€” not the derivative's P&L.
TickerIssuerNotionalPort %@ FilingNow (EOD)Since FilingAllocation
ASNDASCENDIS PHARMA A/S$703.5M18.76%$92.96$274.50+195.3%
18.8%
BIIBBIOGEN INC$148.3M3.95%$203.94$216.12+6.0%
4.0%
CTKBCYTEK BIOSCIENCES INC$143.6M3.83%$10.73$4.59-57.2%
3.8%
AVTEAEROVATE THERAPEUTICS INC$129.2M3.44%β€”β€”
3.4%
DAWNDAY ONE BIOPHARMACEUTICALS I$126.0M3.36%β€”β€”
3.4%
TVTXTRAVERE THERAPEUTICS INC$119.3M3.18%$24.23$56.92+134.9%
3.2%
JANXJANUX THERAPEUTICS INC$105.9M2.82%$12.21$15.54+27.3%
2.8%
PCVXVAXCYTE INC$99.7M2.66%$21.76$58.39+168.3%
2.7%
IMGNIMMUNOGEN INC$97.8M2.61%β€”β€”
2.6%
NKTXNKARTA INC$96.2M2.56%$12.32$3.22-73.9%
2.6%
BLUBELLUS HEALTH INC NEW$94.5M2.52%β€”β€”
2.5%
ITOSITEOS THERAPEUTICS INC$91.0M2.43%β€”β€”
2.4%
VERUXXXXVERU INC$89.3M2.38%β€”β€”
2.4%
DICEDICE THERAPEUTICS INC$80.8M2.16%β€”β€”
2.2%
PEPGPEPGEN INC$80.8M2.15%$9.93$1.76-82.3%
2.1%
FMTXFORMA THERAPEUTICS HLDGS INC$62.1M1.66%β€”β€”
1.7%
ACRSACLARIS THERAPEUTICS INC$61.4M1.64%$13.96$5.56-60.2%
1.6%
PNTPOINT BIOPHARMA GLOBAL INC$61.3M1.63%β€”β€”
1.6%
CLDXCELLDEX THERAPEUTICS INC NEW$55.9M1.49%$26.96$38.37+42.3%
1.5%
WVEWAVE LIFE SCIENCES LTD$55.9M1.49%$3.25$6.26+92.6%
1.5%
VORXXXXVOR BIOPHARMA INC$55.3M1.47%β€”β€”
1.5%
KNTEKINNATE BIOPHARMA INC$53.8M1.43%β€”β€”
1.4%
TYRATYRA BIOSCIENCES INC$51.7M1.38%$7.15$30.62+328.3%
1.4%
GHRSGH RESEARCH PLC$48.9M1.30%$9.98$27.01+170.6%
1.3%
GERNGERON CORP$46.7M1.25%$1.55$1.36-12.3%
1.3%
NTRANATERA INC$46.4M1.24%$35.44$279.32+688.1%
1.2%
ABOSACUMEN PHARMACEUTICALS INC$45.9M1.22%$4.70$2.74-41.7%
1.2%
NSTGQNANOSTRING TECHNOLOGIES$45.5M1.21%β€”β€”
1.2%
RXSTRXSIGHT INC$43.0M1.15%$14.08$5.61-60.2%
1.1%
ENTAENANTA PHARMACEUTICALS INC$42.4M1.13%$47.27$15.11-68.0%
1.1%

Quarter-on-Quarter Activity

Q2 2022 vs. Q1 2022

New Positions (8)

TickerIssuerNotionalSince Filing
VERUXXXXVERU INC$89.3M
PEPGPEPGEN INC$80.8M-82.3%
NSTGQNANOSTRING TECHNOLOGIES$45.5M
HLVXHILLEVAX INC$19.2M
ATHAATHIRA PHARMA INC$5.7M
WHWKAADI BIOSCIENCE INC$4.7M
LABSTANDARD BIOTOOLS INC$3.2M
TERNTERNS PHARMACEUTICALS INC$3.1M

Exited Positions (8)

TickerIssuerNotional
MRTXMIRATI THERAPEUTICS INC$60.4M
MGNXMACROGENICS INC$53.8M
NVAXNOVAVAX INC$51.0M
CNTACENTESSA PHARMACEUTICALS PLC$32.1M
CCXICHEMOCENTRYX INC$29.0M
KALVKALVISTA PHARMACEUTICALS INC$28.4M
EWTXEDGEWISE THERAPEUTICS INC$25.4M
TNGXTANGO THERAPEUTICS INC$17.1M

Increased (8)

TickerIssuerNotionalShares Ξ”Since Filing
ACRSACLARIS THERAPEUTICS INC$30.1M+142.0%-60.2%
WVEWAVE LIFE SCIENCES LTD$40.4M+121.2%+92.6%
TILINSTIL BIO INC$-16.9M+57.5%
ETNB89BIO INC$6.3M+56.7%
NKTXNKARTA INC$32.4M+39.2%-73.9%
DAWNDAY ONE BIOPHARMACEUTICALS I$65.9M+16.2%
CNCECONCERT PHARMACEUTICALS INC$3.7M+9.0%
ANTXAN2 THERAPEUTICS INC$-26.2M+2.2%

Trimmed (8)

TickerIssuerNotionalShares Ξ”
ORTXORCHARD THERAPEUTICS PLC$-5.1M-68.6%
PYXSPYXIS ONCOLOGY INC$-7.0M-58.2%
OLMAOLEMA PHARMACEUTICALS INC$-1.2M-53.7%
ATXSASTRIA THERAPEUTICS INC$-6.2M-39.7%
LIANYLIANBIO$-18.4M-39.6%
VERAVERA THERAPEUTICS INC$-24.7M-19.7%
LRMRLARIMAR THERAPEUTICS INC$-3.2M-19.5%
XLOXILIO THERAPEUTICS INC$-9.3M-17.6%
← Back to Hedge Funds